TECHNICAL ANALYSIS
RMD
ResMed|
TECHNICAL RATING
TECHNICAL SCORE
88 / 100
Summary
Price sits roughly 8.6% above the 20-day, 10.2% above the 50-day and 12.8% above the 200-day moving averages, and a recent Golden cross has formed within the last 30 sessions. Momentum is reinforcing the trend: MACD is above its signal line and RSI(14) is 77.2, an extreme overbought reading, so trend and momentum are aligned but stretched. The share is trading inside the Bollinger bands while volume is running slightly below its 20-day average, which supports the move but limits conviction behind any extension. Watch for RSI to cool below 70 or for price to pull back toward the 20-day moving average as key signs the current extension is reversing.
Price & Moving Averages
Volume
RSI (14)
MACD (12/26/9)
Formula & Methodology
Short-term trendPrice vs. 20-day moving average (weight 10%)
Intermediate trendPrice vs. 50-day moving average (weight 15%)
Long-term regimePrice vs. 200-day moving average (weight 25%)
Cross state50/200 Golden or Death cross (weight 10%)
Momentum + trendMACD 12/26/9 vs signal line (weight 15%)
Momentum bandsRSI (14) state (weight 10%)
VolatilityBollinger-band position (weight 5%)
ConfirmationVolume vs 20-day average (weight 10%)
Rating ruleFormula: the Technical Score is a weighted composite of eight inputs. Trend inputs — price vs. the 20-day (10%), 50-day (15%), and 200-day (25%) moving averages, and the 50/200 Golden or Death cross state (10%) — carry roughly 60% of the weight. Momentum inputs — MACD (12/26/9) vs. its signal line (15%) and RSI (14) state (10%) — carry 25%. Bollinger-band position (5%) and volume vs. the 20-day average (10%) round out the remainder. Each input contributes +1, 0, or -1, weights are re-normalized when a component is unavailable, and the weighted sum is thresholded at +/-0.45 to Bullish, Neutral, or Bearish.
Data Source
Market data sourced from Tiingo. End-of-day prices and volume power the charts and indicators (MA20/50/200, RSI, MACD, Bollinger Bands, Volume) on this page. This page is informational analysis, not investment advice. See Financial Disclaimer.